Daniel J Fehrenbach

12PUBLICATIONS
26CO-AUTHORS
Immunogenetics (incl. genetic immunology)Cardiology (incl. cardiovascular diseases)Foetal development and medicineDevelopmental genetics (incl. sex determination)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 30, 2026
Galectin-1 Is a Marker but Not a Mediator of Heart Failure With Preserved Ejection Fraction.

Jean W Wassenaar, C Duncan Smart, Daniel J Fehrenbach

|Jan 30, 2025
Bone Marrow Niche in Cardiometabolic Disease: Mechanisms and Therapeutic Potential.

Zachary A Kohutek, Heather L Caslin, Daniel J Fehrenbach

|Sep 20, 2024
Intact NOX2 in T Cells Mediates Pregnancy-Induced Renal Damage in Dahl SS Rats.

John Henry Dasinger, Justine M Abais-Battad, Samuel D Walton

|May 17, 2024
Sex-Dependency of T Cell-Induced Salt-Sensitive Hypertension and Kidney Damage.

Justine M Abais-Battad, John Henry Dasinger, Hayley Lund

|Apr 19, 2024
Mitochondrial CypD Acetylation Promotes Endothelial Dysfunction and Hypertension.

Anna Dikalova, Daniel Fehrenbach, Vladimir Mayorov

|Sep 28, 2022
A Single Nucleotide Polymorphism in SH2B3/LNK Promotes Hypertension Development and Renal Damage.

Matthew R Alexander, Samuel Hank, Bethany L Dale

Pageof 2